Anzeige
Mehr »
Donnerstag, 17.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiSarepta to lay off about 500 employees after Duchenne gene therapy setbacks
MiAstraZeneca rare disease drug fails key trial tests
MiJ&J absorbs Stelara, tariff hits to deliver beat-and-raise quarter
MiModerna's latest approval again reveals FDA rift over COVID vaccines
Mi33 states pick up CMS program to pay for sickle cell gene therapies
DiCancer drugmaker LaNova to sell to China's Sino Biopharm
DiHengrui, Kailera say dual-acting obesity shot succeeds in China study
DiVertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug
MoAstraZeneca blood pressure drug succeeds in late-stage trial
MoPrivate equity firms back PCI Pharma in bet on drug production
MoFDA rejects Ultragenyx gene therapy over manufacturing concerns
MoTakeda to seek approval of new kind of narcolepsy drug after study data
MoFrom data to decisions: How pharma can move faster without sacrificing trust
FrJazz names new CEO; Ultragenyx, Mereo shares slide on trial update
FrWith Verona Pharma deal, Merck wagers on strength of lung drug's patents
FrFDA turns back Capricor's Duchenne cell therapy
10.07.Soleno sales of new Prader-Willi drug rise faster than expected
10.07.Moderna COVID vaccine gets full approval for children
10.07.FDA, in policy shift, publishes some drug rejection letters
10.07.AbbVie to pay $700M for trispecific drug from Ichnos Glenmark
10.07.Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding
09.07.Lilly gets FDA OK of modified dosing for Alzheimer's drug
09.07.Merck to buy Verona Pharma and its lung drug in $10B deal
09.07.Gilead signs lenacapavir access deal; Arvinas CEO to step down
09.07.Actithera draws new investors to radiopharma drug pitch